Cargando…
Expression and copy number gains of the RET gene in 631 early and mid stage non‐small cell lung cancer cases
BACKGROUND: To identify whether RET is a potential target for NSCLC treatment, we examined the status of the RET gene in 631 early and mid stage NSCLC cases from south central China. METHODS: RET expression was identified by Western blot. RET‐positive expression samples were verified by immunohistoc...
Autores principales: | Tan, Ling, Hu, Yerong, Tao, Yongguang, Wang, Bin, Xiao, Jun, Tang, Zhenjie, Lu, Ting, Tang, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879055/ https://www.ncbi.nlm.nih.gov/pubmed/29473341 http://dx.doi.org/10.1111/1759-7714.12603 |
Ejemplares similares
-
A patient with RET D631Y mutation present with pheochromocytoma
por: Kim, Jung Min
Publicado: (2021) -
Clinical features and signaling effects of RET D631Y variant multiple endocrine neoplasia type 2 (MEN2)
por: Lee, Ji-young, et al.
Publicado: (2022) -
RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency
por: Ramone, Teresa, et al.
Publicado: (2020) -
A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies
por: Platt, Adam, et al.
Publicado: (2015) -
Unproductive Effects of ALK Gene Amplification and Copy Number Gain in Non-Small-Cell Lung Cancer. ALK Gene Amplification and Copy Gain in NSCLC
por: Zito Marino, Federica, et al.
Publicado: (2020)